<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01556828</url>
  </required_header>
  <id_info>
    <org_study_id>LYMNHL0091</org_study_id>
    <secondary_id>SU-03142012-9329</secondary_id>
    <secondary_id>21750</secondary_id>
    <nct_id>NCT01556828</nct_id>
  </id_info>
  <brief_title>Analysis of Cutaneous and Hematologic Disorders by High-Throughput Nucleic Acid Sequencing</brief_title>
  <official_title>Analysis of Cutaneous and Hematologic Disorders by High-Throughput Nucleic Acid Sequencing</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Stanford University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of this study is to identify genetic changes associated with the initiation,&#xD;
      progression, and treatment response of response of cutaneous and hematologic disorders using&#xD;
      recently developed high-throughput sequencing technologies. The improved understanding of the&#xD;
      genetic changes associated with cutaneous and hematologic disorders may lead to improved&#xD;
      diagnostic, prognostic and therapeutic options for these disorders.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <start_date>June 2011</start_date>
  <completion_date type="Actual">June 2014</completion_date>
  <primary_completion_date type="Actual">June 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of mutations</measure>
    <time_frame>2 years</time_frame>
    <description>Identify mutations, changes in DNA copy number, structural rearrangements, or altered coding and non-coding RNA expression</description>
  </primary_outcome>
  <enrollment type="Actual">70</enrollment>
  <condition>Cutaneous Lymphoma</condition>
  <condition>Other Skin Disorders</condition>
  <condition>Mycosis Fungoides</condition>
  <condition>Cutaneous T-cell Lymphoma</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      whole blood tissue&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Eligible subjects will be identified and recruited by referral from that individual's&#xD;
        treating physician, mainly Stanford-affiliated dermatologists, oncologists, and&#xD;
        hematologists.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  18 years of age or older&#xD;
&#xD;
          -  Patient meets the clinical and/or pathologic criteria for the cutaneous or hematologic&#xD;
             disorder being examined.&#xD;
&#xD;
          -  Patient is willing to provide skin biopsies and five 10 mL tubes of peripheral blood.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        - Less than 18 years of age&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Paul Khavari, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stanford University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Stanford University, School of Medicine</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2016</verification_date>
  <study_first_submitted>March 14, 2012</study_first_submitted>
  <study_first_submitted_qc>March 15, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 16, 2012</study_first_posted>
  <last_update_submitted>June 22, 2016</last_update_submitted>
  <last_update_submitted_qc>June 22, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 24, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mycoses</mesh_term>
    <mesh_term>Lymphoma</mesh_term>
    <mesh_term>Mycosis Fungoides</mesh_term>
    <mesh_term>Lymphoma, T-Cell, Cutaneous</mesh_term>
    <mesh_term>Hematologic Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

